A roundup of personnel changes by medical device, diagnostics and life science companies around the nation:
-
Caldera Medical appoints Joseph P. Kelly as vice president of sales
Caldera Medical, Inc. announced the appointment of Joseph P. Kelly as Vice President of Sales. In this role, Joe will report to Bryon L. Merade, Chief Executive Officer and Chairman of the Board. Mr. Kelly joins Caldera Medical after 12 years at Diagnostic Products Corporation where he built a sales force from 25 to over 200 sales representatives and in turn grew DPC’s domestic sales revenues from $20 million to $160 million under his leadership.
Read more -
Metamark Genetics announces new chief scientific officer, new board members
Metamark Genetics, Inc., a privately held molecular diagnostics company developing innovative personalized medicine approaches to optimize cancer care, announced today the appointment of Peter Blume-Jensen, M.D., Ph.D. as Chief Scientific Officer and tapped three new members for its board of directors.
Read more -
Molecular Response taps new CEO
Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the appointment of Cyrus K. Mirsaidi to Chief Executive Officer.
Read more -
West Wireless Health Institute names SVP of commercial engineering
The West Wireless Health Institute (WWHI) today announced the appointment of Eric Collins as senior vice president of commercial engineering and member of the Institute’s management committee. In this new role, Collins and his team will drive the Institute’s strategies for converting wireless health product concepts and prototypes from early stage development into comprehensive solutions that are ready to be used in the marketplace by health care providers and patients. Collins brings 25 years of wireless product and business development experience to the Institute.
Read more -
GenomeQuest taps Wilson
for science advisory board
GenomeQuest, a global leader in sequence data management, today announced the appointment of Richard K. Wilson, Ph.D., Professor of Genetics and Director of The Genome Center at Washington University School of Medicine, to its Science Advisory Board.
Read more -
Vermillion names new director of reimbursement
Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced the appointment of Jeffrey M. Salzman as Corporate Director of Reimbursement. In his role, Mr. Salzman will be responsible for developing and executing payor strategies for Vermillion.
Read more
